SPAC backs Revelation to tackle respiratory viral infections
SPAC backs Revelation to tackle respiratory viral infections ntaylor Mon, [...]
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce cell death
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce [...]
BeyondSpring, flying high from phase 3 success, sells Chinese rights to cancer drug
BeyondSpring, flying high from phase 3 success, sells Chinese rights [...]
Agenus, with FDA approval in sight, showcases anti-PD-1 data
Agenus, with FDA approval in sight, showcases anti-PD-1 data ntaylor [...]
AstraZeneca’s $39B Alexion buyout bears fruit, yielding late-phase win for potential blockbuster rare disease drug
AstraZeneca’s $39B Alexion buyout bears fruit, yielding late-phase win for [...]
Sesen, still reeling from FDA rejection, pulls filing for EU approval of cancer drug
Sesen, still reeling from FDA rejection, pulls filing for EU [...]
Replimune axes CMO role and CMO Pirzkall along with it
Replimune axes CMO role and CMO Pirzkall along with it [...]
Unraveling the link between migraines and protection against diabetes
Unraveling the link between migraines and protection against diabetes klahucik [...]
Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial
Bristol-backed Cardior gets $75M to run midphase antisense heart failure [...]
Improving CAR-T cell therapy with more sensitive tumor identification
Improving CAR-T cell therapy with more sensitive tumor identification aliu [...]